Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

TumGrowth: An open-access web tool for the statistical analysis of tumor growth curves.

Enot DP, Vacchelli E, Jacquelot N, Zitvogel L, Kroemer G.

Oncoimmunology. 2018 Aug 1;7(9):e1462431. doi: 10.1080/2162402X.2018.1462431. eCollection 2018.

2.

Aspirin Recapitulates Features of Caloric Restriction.

Pietrocola F, Castoldi F, Markaki M, Lachkar S, Chen G, Enot DP, Durand S, Bossut N, Tong M, Malik SA, Loos F, Dupont N, Mariño G, Abdelkader N, Madeo F, Maiuri MC, Kroemer R, Codogno P, Sadoshima J, Tavernarakis N, Kroemer G.

Cell Rep. 2018 Feb 27;22(9):2395-2407. doi: 10.1016/j.celrep.2018.02.024.

3.

Predictors of responses to immune checkpoint blockade in advanced melanoma.

Jacquelot N, Roberti MP, Enot DP, Rusakiewicz S, Ternès N, Jegou S, Woods DM, Sodré AL, Hansen M, Meirow Y, Sade-Feldman M, Burra A, Kwek SS, Flament C, Messaoudene M, Duong CPM, Chen L, Kwon BS, Anderson AC, Kuchroo VK, Weide B, Aubin F, Borg C, Dalle S, Beatrix O, Ayyoub M, Balme B, Tomasic G, Di Giacomo AM, Maio M, Schadendorf D, Melero I, Dréno B, Khammari A, Dummer R, Levesque M, Koguchi Y, Fong L, Lotem M, Baniyash M, Schmidt H, Svane IM, Kroemer G, Marabelle A, Michiels S, Cavalcanti A, Smyth MJ, Weber JS, Eggermont AM, Zitvogel L.

Nat Commun. 2017 Sep 19;8(1):592. doi: 10.1038/s41467-017-00608-2.

4.

Immune biomarkers for prognosis and prediction of responses to immune checkpoint blockade in cutaneous melanoma.

Jacquelot N, Pitt JM, Enot DP, Roberti MP, Duong CPM, Rusakiewicz S, Eggermont AM, Zitvogel L.

Oncoimmunology. 2017 Mar 7;6(8):e1299303. doi: 10.1080/2162402X.2017.1299303. eCollection 2017. Review.

5.

[Chemokine receptors expression on T cells: contribution to diagnosis of melanoma metastasis dissemination status].

Jacquelot N, Enot DP, Flament C, Dalle S, Zitvogel L.

Med Sci (Paris). 2016 8-9;32(8-9):690-2. doi: 10.1051/medsci/20163208010. Epub 2016 Sep 12. French. No abstract available.

6.

Caloric Restriction Mimetics Enhance Anticancer Immunosurveillance.

Pietrocola F, Pol J, Vacchelli E, Rao S, Enot DP, Baracco EE, Levesque S, Castoldi F, Jacquelot N, Yamazaki T, Senovilla L, Marino G, Aranda F, Durand S, Sica V, Chery A, Lachkar S, Sigl V, Bloy N, Buque A, Falzoni S, Ryffel B, Apetoh L, Di Virgilio F, Madeo F, Maiuri MC, Zitvogel L, Levine B, Penninger JM, Kroemer G.

Cancer Cell. 2016 Jul 11;30(1):147-160. doi: 10.1016/j.ccell.2016.05.016.

7.

Impact of Pattern Recognition Receptors on the Prognosis of Breast Cancer Patients Undergoing Adjuvant Chemotherapy.

Vacchelli E, Enot DP, Pietrocola F, Zitvogel L, Kroemer G.

Cancer Res. 2016 Jun 1;76(11):3122-6. doi: 10.1158/0008-5472.CAN-16-0294. Epub 2016 May 16. Review.

8.

Chemokine receptor patterns in lymphocytes mirror metastatic spreading in melanoma.

Jacquelot N, Enot DP, Flament C, Vimond N, Blattner C, Pitt JM, Yamazaki T, Roberti MP, Daillère R, Vétizou M, Poirier-Colame V, Semeraro M, Caignard A, Slingluff CL Jr, Sallusto F, Rusakiewicz S, Weide B, Marabelle A, Kohrt H, Dalle S, Cavalcanti A, Kroemer G, Di Giacomo AM, Maio M, Wong P, Yuan J, Wolchok J, Umansky V, Eggermont A, Zitvogel L.

J Clin Invest. 2016 Mar 1;126(3):921-37. doi: 10.1172/JCI80071. Epub 2016 Feb 8.

9.

Immunophenotyping of Stage III Melanoma Reveals Parameters Associated with Patient Prognosis.

Jacquelot N, Roberti MP, Enot DP, Rusakiewicz S, Semeraro M, Jégou S, Flores C, Chen L, Kwon BS, Borg C, Weide B, Aubin F, Dalle S, Kohrt H, Ayyoub M, Kroemer G, Marabelle A, Cavalcanti A, Eggermont A, Zitvogel L.

J Invest Dermatol. 2016 May;136(5):994-1001. doi: 10.1016/j.jid.2015.12.042. Epub 2016 Jan 29.

10.

Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota.

Vétizou M, Pitt JM, Daillère R, Lepage P, Waldschmitt N, Flament C, Rusakiewicz S, Routy B, Roberti MP, Duong CP, Poirier-Colame V, Roux A, Becharef S, Formenti S, Golden E, Cording S, Eberl G, Schlitzer A, Ginhoux F, Mani S, Yamazaki T, Jacquelot N, Enot DP, Bérard M, Nigou J, Opolon P, Eggermont A, Woerther PL, Chachaty E, Chaput N, Robert C, Mateus C, Kroemer G, Raoult D, Boneca IG, Carbonnel F, Chamaillard M, Zitvogel L.

Science. 2015 Nov 27;350(6264):1079-84. doi: 10.1126/science.aad1329. Epub 2015 Nov 5.

11.

Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1.

Vacchelli E, Ma Y, Baracco EE, Sistigu A, Enot DP, Pietrocola F, Yang H, Adjemian S, Chaba K, Semeraro M, Signore M, De Ninno A, Lucarini V, Peschiaroli F, Businaro L, Gerardino A, Manic G, Ulas T, Günther P, Schultze JL, Kepp O, Stoll G, Lefebvre C, Mulot C, Castoldi F, Rusakiewicz S, Ladoire S, Apetoh L, Bravo-San Pedro JM, Lucattelli M, Delarasse C, Boige V, Ducreux M, Delaloge S, Borg C, André F, Schiavoni G, Vitale I, Laurent-Puig P, Mattei F, Zitvogel L, Kroemer G.

Science. 2015 Nov 20;350(6263):972-8. doi: 10.1126/science.aad0779. Epub 2015 Oct 29.

12.

Negative prognostic impact of regulatory T cell infiltration in surgically resected esophageal cancer post-radiochemotherapy.

Vacchelli E, Semeraro M, Enot DP, Chaba K, Poirier Colame V, Dartigues P, Perier A, Villa I, Rusakiewicz S, Gronnier C, Goéré D, Mariette C, Zitvogel L, Kroemer G.

Oncotarget. 2015 Aug 28;6(25):20840-50.

13.

Metabolomic analyses reveal that anti-aging metabolites are depleted by palmitate but increased by oleate in vivo.

Enot DP, Niso-Santano M, Durand S, Chery A, Pietrocola F, Vacchelli E, Madeo F, Galluzzi L, Kroemer G.

Cell Cycle. 2015 Aug 3;14(15):2399-407. doi: 10.1080/15384101.2015.1064206. Epub 2015 Jun 22.

14.

Spermidine induces autophagy by inhibiting the acetyltransferase EP300.

Pietrocola F, Lachkar S, Enot DP, Niso-Santano M, Bravo-San Pedro JM, Sica V, Izzo V, Maiuri MC, Madeo F, Mariño G, Kroemer G.

Cell Death Differ. 2015 Mar;22(3):509-16. doi: 10.1038/cdd.2014.215. Epub 2014 Dec 19.

15.

Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy.

Sistigu A, Yamazaki T, Vacchelli E, Chaba K, Enot DP, Adam J, Vitale I, Goubar A, Baracco EE, Remédios C, Fend L, Hannani D, Aymeric L, Ma Y, Niso-Santano M, Kepp O, Schultze JL, Tüting T, Belardelli F, Bracci L, La Sorsa V, Ziccheddu G, Sestili P, Urbani F, Delorenzi M, Lacroix-Triki M, Quidville V, Conforti R, Spano JP, Pusztai L, Poirier-Colame V, Delaloge S, Penault-Llorca F, Ladoire S, Arnould L, Cyrta J, Dessoliers MC, Eggermont A, Bianchi ME, Pittet M, Engblom C, Pfirschke C, Préville X, Uzè G, Schreiber RD, Chow MT, Smyth MJ, Proietti E, André F, Kroemer G, Zitvogel L.

Nat Med. 2014 Nov;20(11):1301-9. doi: 10.1038/nm.3708. Epub 2014 Oct 26.

PMID:
25344738
16.

Regulation of autophagy by cytosolic acetyl-coenzyme A.

Mariño G, Pietrocola F, Eisenberg T, Kong Y, Malik SA, Andryushkova A, Schroeder S, Pendl T, Harger A, Niso-Santano M, Zamzami N, Scoazec M, Durand S, Enot DP, Fernández ÁF, Martins I, Kepp O, Senovilla L, Bauvy C, Morselli E, Vacchelli E, Bennetzen M, Magnes C, Sinner F, Pieber T, López-Otín C, Maiuri MC, Codogno P, Andersen JS, Hill JA, Madeo F, Kroemer G.

Mol Cell. 2014 Mar 6;53(5):710-25. doi: 10.1016/j.molcel.2014.01.016. Epub 2014 Feb 20.

17.

The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide.

Viaud S, Saccheri F, Mignot G, Yamazaki T, Daillère R, Hannani D, Enot DP, Pfirschke C, Engblom C, Pittet MJ, Schlitzer A, Ginhoux F, Apetoh L, Chachaty E, Woerther PL, Eberl G, Bérard M, Ecobichon C, Clermont D, Bizet C, Gaboriau-Routhiau V, Cerf-Bensussan N, Opolon P, Yessaad N, Vivier E, Ryffel B, Elson CO, Doré J, Kroemer G, Lepage P, Boneca IG, Ghiringhelli F, Zitvogel L.

Science. 2013 Nov 22;342(6161):971-6. doi: 10.1126/science.1240537.

18.

Cisplatin resistance associated with PARP hyperactivation.

Michels J, Vitale I, Galluzzi L, Adam J, Olaussen KA, Kepp O, Senovilla L, Talhaoui I, Guegan J, Enot DP, Talbot M, Robin A, Girard P, Oréar C, Lissa D, Sukkurwala AQ, Garcia P, Behnam-Motlagh P, Kohno K, Wu GS, Brenner C, Dessen P, Saparbaev M, Soria JC, Castedo M, Kroemer G.

Cancer Res. 2013 Apr 1;73(7):2271-80. doi: 10.1158/0008-5472.CAN-12-3000.

19.

Synergistic interaction between cisplatin and PARP inhibitors in non-small cell lung cancer.

Michels J, Vitale I, Senovilla L, Enot DP, Garcia P, Lissa D, Olaussen KA, Brenner C, Soria JC, Castedo M, Kroemer G.

Cell Cycle. 2013 Mar 15;12(6):877-83. doi: 10.4161/cc.24034. Epub 2013 Feb 21.

20.

Systematic characterization of amplitude-integrated EEG signals for monitoring the preterm brain.

Griesmaier E, Enot DP, Bachmann M, Neubauer V, Hellström-Westas L, Kiechl-Kohlendorfer U, Keller M.

Pediatr Res. 2013 Feb;73(2):226-35. doi: 10.1038/pr.2012.171. Epub 2012 Nov 22.

PMID:
23174705
21.

Metabolite profiles reveal energy failure and impaired beta-oxidation in liver of mice with complex III deficiency due to a BCS1L mutation.

Kotarsky H, Keller M, Davoudi M, Levéen P, Karikoski R, Enot DP, Fellman V.

PLoS One. 2012;7(7):e41156. doi: 10.1371/journal.pone.0041156. Epub 2012 Jul 19.

22.

Hepatic induction of cholesterol biosynthesis reflects a remote adaptive response to pneumococcal pneumonia.

Weber M, Lambeck S, Ding N, Henken S, Kohl M, Deigner HP, Enot DP, Igwe EI, Frappart L, Kiehntopf M, Claus RA, Kamradt T, Weih D, Vodovotz Y, Briles DE, Ogunniyi AD, Paton JC, Maus UA, Bauer M.

FASEB J. 2012 Jun;26(6):2424-36. doi: 10.1096/fj.11-191957. Epub 2012 Mar 13.

PMID:
22415311
23.

Inflammatory-induced hibernation in the fetus: priming of fetal sheep metabolism correlates with developmental brain injury.

Keller M, Enot DP, Hodson MP, Igwe EI, Deigner HP, Dean J, Bolouri H, Hagberg H, Mallard C.

PLoS One. 2011;6(12):e29503. doi: 10.1371/journal.pone.0029503. Epub 2011 Dec 29.

24.

Bioinformatics for mass spectrometry-based metabolomics.

Enot DP, Haas B, Weinberger KM.

Methods Mol Biol. 2011;719:351-75. doi: 10.1007/978-1-61779-027-0_16.

PMID:
21370092
25.

Targeted metabolomics for biomarker discovery.

Griffiths WJ, Koal T, Wang Y, Kohl M, Enot DP, Deigner HP.

Angew Chem Int Ed Engl. 2010 Jul 26;49(32):5426-45. doi: 10.1002/anie.200905579. Review.

PMID:
20629054
26.

Complexity and pitfalls of mass spectrometry-based targeted metabolomics in brain research.

Urban M, Enot DP, Dallmann G, Körner L, Forcher V, Enoh P, Koal T, Keller M, Deigner HP.

Anal Biochem. 2010 Nov 15;406(2):124-31. doi: 10.1016/j.ab.2010.07.002. Epub 2010 Jul 7.

PMID:
20619249
27.

Metabolite fingerprinting of urine suggests breed-specific dietary metabolism differences in domestic dogs.

Beckmann M, Enot DP, Overy DP, Scott IM, Jones PG, Allaway D, Draper J.

Br J Nutr. 2010 Apr;103(8):1127-38. doi: 10.1017/S000711450999300X. Epub 2009 Dec 15.

PMID:
20003623
28.

Metabolite signal identification in accurate mass metabolomics data with MZedDB, an interactive m/z annotation tool utilising predicted ionisation behaviour 'rules'.

Draper J, Enot DP, Parker D, Beckmann M, Snowdon S, Lin W, Zubair H.

BMC Bioinformatics. 2009 Jul 21;10:227. doi: 10.1186/1471-2105-10-227.

29.

Metabolomic analysis reveals a common pattern of metabolic re-programming during invasion of three host plant species by Magnaporthe grisea.

Parker D, Beckmann M, Zubair H, Enot DP, Caracuel-Rios Z, Overy DP, Snowdon S, Talbot NJ, Draper J.

Plant J. 2009 Sep;59(5):723-37. doi: 10.1111/j.1365-313X.2009.03912.x. Epub 2009 May 12.

30.

High-throughput, nontargeted metabolite fingerprinting using nominal mass flow injection electrospray mass spectrometry.

Beckmann M, Parker D, Enot DP, Duval E, Draper J.

Nat Protoc. 2008;3(3):486-504. doi: 10.1038/nprot.2007.500.

PMID:
18323818
31.

Explanatory signal interpretation and metabolite identification strategies for nominal mass FIE-MS metabolite fingerprints.

Overy DP, Enot DP, Tailliart K, Jenkins H, Parker D, Beckmann M, Draper J.

Nat Protoc. 2008;3(3):471-85. doi: 10.1038/nprot.2007.512.

PMID:
18323817
32.

Preprocessing, classification modeling and feature selection using flow injection electrospray mass spectrometry metabolite fingerprint data.

Enot DP, Lin W, Beckmann M, Parker D, Overy DP, Draper J.

Nat Protoc. 2008;3(3):446-70. doi: 10.1038/nprot.2007.511.

PMID:
18323816
33.

Rice blast infection of Brachypodium distachyon as a model system to study dynamic host/pathogen interactions.

Parker D, Beckmann M, Enot DP, Overy DP, Rios ZC, Gilbert M, Talbot N, Draper J.

Nat Protoc. 2008;3(3):435-45. doi: 10.1038/nprot.2007.499.

PMID:
18323815
34.
35.

Predicting interpretability of metabolome models based on behavior, putative identity, and biological relevance of explanatory signals.

Enot DP, Beckmann M, Overy D, Draper J.

Proc Natl Acad Sci U S A. 2006 Oct 3;103(40):14865-70. Epub 2006 Sep 21.

36.

Hierarchical metabolomics demonstrates substantial compositional similarity between genetically modified and conventional potato crops.

Catchpole GS, Beckmann M, Enot DP, Mondhe M, Zywicki B, Taylor J, Hardy N, Smith A, King RD, Kell DB, Fiehn O, Draper J.

Proc Natl Acad Sci U S A. 2005 Oct 4;102(40):14458-62. Epub 2005 Sep 26.

37.

Gaussian process: an efficient technique to solve quantitative structure-property relationship problems.

Enot DP, Gautier R, Le Marouille JY.

SAR QSAR Environ Res. 2001;12(5):461-9.

PMID:
11813811

Supplemental Content

Support Center